IP Library Granted Patent US 11,806,136
Granted Patent B2
US 11,806,136 · App. 18/093,532 · Granted Nov 7, 2023

Wired implantable monolithic integrated sensor circuit

Inventors: Muhammad Mujeeb-U-Rahman (Irvine, CA); Meisam Honarvar Nazari (Irvine, CA); Mehmet Sencan (Tustin, CA)
A61B5/14532A61B5/0004A61B5/14865A61B5/6849
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,806,136
App. No.
18/093,532
Granted
Nov 7, 2023
Kind
B2
Abstract

There is provided a glucose sensor system comprising: a transmitter ( 2 ) for containing a battery ( 212 ), the transmitter being for placement on top of patient skin; a transcutaneous connector ( 3 ) comprising at least one conductive path; and an implantable monolithic integrated circuit (I) for placement beneath the patient skin, wherein the implantable monolithic integrated circuit comprises a potentiostat and an electrochemical sensing element; wherein the potentiostat is electrically coupled to the transmitter ( 2 ) via the transcutaneous connector ( 3 ), and the electrochemical sensing element is configured to sense glucose concentration and generate an electrical signal representative of the glucose concentration, and wherein the potentiostat is electrically connected to the electrochemical sensing element.

Claims (7)

1. A glucose sensor system comprising:

a transmitter for containing a battery, the transmitter being for placement on top of patient skin;

a transcutaneous connector comprising at least one conductive path; and

an implantable monolithic integrated circuit for placement beneath the patient skin, wherein the implantable monolithic integrated circuit comprises a potentiostat and an electrochemical element, said electrochemical sensing element comprising at least one working electrode patterned to increase surface area and coated with a chemistry which converts glucose concentration into current;

wherein the potentiostat is electrically coupled to the transmitter via the transcutaneous connector, and the electrochemical sensing element is configured to sense glucose concentration and generate an electric signal representative of the glucose concentration, and wherein the potentiostat is electrically connected to the electrochemical sensing element.

2. The continuous analyte monitoring system of claim 1 , wherein the potentiostat is connected within half a millimeter to the entirety of at least one working electrode.

3. The continuous analyte monitoring system of claim 1 , wherein the at least one working electrode is patterned by forming holes.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2025
From: INTEGRATED MEDICAL SENSORS
To: ADVANCED INTELLIGENT SENSORS
Reel/Frame 070200/0652 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2023
From: NAZARI, MEISAM HONARVAR
To: INTEGRATED MEDICAL SENSORS
Reel/Frame 064796/0306 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2023
From: MUJEEB-U-RAHMAN, MUHAMMAD
To: INTEGRATED MEDICAL SENSORS
Reel/Frame 064770/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2023
From: SENCAN, MEHMET
To: INTEGRATED MEDICAL SENSORS
Reel/Frame 064770/0280 →
Continuity (7)
Continuation 17993516
Provisional Application 63336299 · Apr 28, 2022
Provisional Application 63333443 · Apr 21, 2022
Provisional Application 63318790 · Mar 11, 2022
Provisional Application 63298632 · Jan 12, 2022
Provisional Application 63239484 · Sep 1, 2021
Related Publication 20230277095A1 · Sep 7, 2023